Increasing Adoption of Programmable and Anti-siphon Shunt Valves to Foster Growth of the Hydrocephalus Shunt Market

According to the latest research by the company, the global hydrocephalus shunt market is expected to be valued at US$ 599.7 Mn, by 2028 end. The report on the hydrocephalus shunt market further projects significant growth potential with average year-on-year growth rate pegged at 2.3% through 2028.

The growing incidence of hydrocephalus due to increasing number of accident cases is the major factor expected to drive the growth hydrocephalus shunt market. Various private and government organizations are focusing on spreading awareness regarding hydrocephalus, which is also expected to favor the growth of the hydrocephalus shunt market over the forecast period. Half of the patients experience complications such as shunt blockage and drainage program and need shunt revision post hydrocephalus shunt revision surgery.

According to the UK Shunt Registry, around 3,000 shunt operations are performed in the U.K. every year: 1660 pediatric (33.5% primary and 66.5% revisions) and 1400 adult (53% primary and 47% revisions). Increasing adoption of magnetically programmable valve over fixed pressure valves favors the growth of the market. Moreover, availability of MRI-compatible programmable hydrocephalus valves is also expected to propel the growth of the hydrocephalus shunt market. These programmable hydrocephalus valves are suitable for up to magnetic field interaction at 3 Tesla or less when the specific guidelines are followed. Moreover, anti-siphon devices are gaining traction to avoid siphon effect namely over drainage of cerebrospinal fluid. Moreover, strong reimbursement policies for hydrocephalus diagnosis and treatment are expected to boost the growth of the hydrocephalus shunt market.

Request Report Sample@ https://www.futuremarketinsights.com/reports/sample/rep-gb-7756

However, stringent regulatory policies for approval of hydrocephalus is expected to considerably impact the growth of the hydrocephalus shunt market. Moreover, risks and complications associated with shunt implant is the other factor expected to hamper the growth of the hydrocephalus shunt market. Besides, the high cost of surgery and lack of neurologists are the major challenges in the growth of the hydrocephalus shunt market.

The company has segmented the global hydrocephalus shunt market based on product type, procedure type, age group, and regions. Based on product type, the hydrocephalus shunt market is segmented into hydrocephalus valves and hydrocephalus catheters. The hydrocephalus valves segment is expected to represent the high revenue share in the hydrocephalus shunt market due to increasing adoption of adjustable pressure valves. By procedure type, the hydrocephalus shunt market is segmented into ventriculoperitoneal, ventriculoatrial, lumboperitoneal and ventriculopleural. The ventriculoperitoneal segment is expected to contribute high value share in the global hydrocephalus shunt market. Other procedures are performed when the complication is associated with ventriculoperitoneal procedure or risk of infection peritoneal region. Based on the age group, the hydrocephalus shunt market is segmented into pediatric and adult segment.  In terms of revenue, the pediatric segment is projected to hold significant revenue share in the global hydrocephalus shunt market over the forecast period as a large number of revision surgeries are performed among pediatric patients.

On the basis of region, the global hydrocephalus shunt market has been segmented into North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding China & Japan, China, Japan, and the Middle East & Africa. North America is expected to contribute large revenue share in the global hydrocephalus shunt market. The demand for hydrocephalus shunt has increased in North America, as the prevalence of hydrocephalus is high in the U.S. as well as due to increasing healthcare expenditure. The Asia Pacific excluding China and Japan is expected to witness the high growth due to increasing government funding and support for hydrocephalus treatment. Western Europe is expected to contribute second large share in the global hydrocephalus shunt market due to favorable reimbursement policies and adoption of advance surgical methods.

Request to Browse Report Customization@ https://www.futuremarketinsights.com/customization-available/rep-gb-7756

The report tracks some of the key companies operating in the global hydrocephalus shunt market. Representative players included in the report are Medtronic Plc., B. Braun Melsungen AG, Integra LifeSciences Corporation, Natus Medical Incorporated, Tokibo Co., Ltd. (Sophysa SA), Christoph Miethke GmbH & Co. KG and others. Manufacturers are focusing on the development of new shunt valves to diminish complications and risk associated with the shunt, which will create enormous growth opportunities for them over the forecast period.

Increasing Demand for Endodontics and Orthodontics Due to Increasing Oral Diseases and Dental Caries

According to the World Health Organization (WHO), oral diseases are the fourth-most expensive diseases to treat in developed as well as developing countries. Dental caries is one of the main oral health problems in a majority of th industrialized countries. Endodontic and orthodontics products are used for these problem, and both are a branch of dentistry that focus on diagnosing tooth pain, performing root canal treatment, and correcting teeth and jaws that are positioned improperly.

The growing prevalence of dental caries among children up to 12 years of age, and the rising incidences of oral diseases promote the demand for dental caries, which includes endodontic and orthodontics products. An increasing number of qualified dental professionals, worldwide, would increase access to dental care products, which include endodontic and orthodontics products. These products are expected to trigger the growth of the global endodontic and orthodontics market over the forecast period.

Consumer are assumed to demand dental services for satisfaction-yielding attributes embodied in them. Increasing awareness towards different treatment options for dental caries has led to the growing demand for dental consumables in endodontic and orthodontics market. The number of people reporting to dentists for routine dental checkups is increasing, and a regular visit to the dentist is becoming a part of lifestyle practices. In countries such as China and Australia, people are giving more importance to the aesthetic aspects of dental products, which is expected to boost the orthodontics and endodontic market over the forecast period. Increasing consumer preference for discounted products. The discount products is growing at the cost of the premium segment of orthodontics and endodontic. Dental services are not covered under public insurance. Thus, the orthodontics and endodontic market entirely follows the consumer perception of dental health.

A sample of this report is available upon request @ https://www.futuremarketinsights.com/reports/sample/rep-gb-7753

A majority of dental hospitals in China have online appointment systems. Healthcare-related mobile apps such as Practo help patients find dentists near them, and allow them to book an online appointment. The growing dental care industry is expected to be another factor driving the growth of the endodontic and orthodontics market.

Increasing trade of endodontic and orthodontics, dental materials, supplies, and consumables in many countries is expected to boost the growth of the endodontic and orthodontics market. Moreover, increasing awareness towards oral hygiene is expected to drive the growth of the endodontic and orthodontics market.

Upper middle-class population is purchasing more than single dental coverage policies in order to fill the gap between cost of dental restoration and reconstruction services and amount reimbursable by public healthcare policies.

With the increasing presence of private dental insurance subscriptions, small group practices have started. Consolidation of the dental industry has led to the lowering of the out-of-pocket cost for dental services, due to the implementation of Protection and Affordable Care Act (PPACA) in the U.S. The rising disposable income of the middle-class population across the globe also has led to changing customer approach towards dental caries treatment.

The endodontic and orthodontics market is segmented on the basis of product and end user.

Based on product type, the endodontic and orthodontics market is segmented into endodontic and orthodontics products. Based on endodontic products, the endodontic and orthodontics market is segmented into permanent sealers, files, obturation devices, and others. Based on orthodontics product, the endodontic and orthodontics market is segmented into dental braces, molar bands, wires, retainers, and others. Based on end user, the endodontic and orthodontics market is segmented into dental laboratories, dental hospitals, dental clinics, and others.

In terms of revenue, the endodontic type segment in the endodontic and orthodontics market is expected to hold significant share over the forecast period. In the end user segment of endodontic and orthodontics market, dental laboratories, dental hospitals, dental clinics, and others in the endodontic and orthodontics market are expected to exhibit limited investment opportunities in terms of revenue through 2028.

Methodology With Latest Advancements and Application @ https://www.futuremarketinsights.com/askus/rep-gb-7753

Endodontic and orthodontics market report tracks some of the key companies operating in the endodontic and orthodontics market, such as Dentsply Sirona, Inc., 3M, Align Technology, Inc, DENTAURUM GmbH & Co. KG, FKG Dentaire SA, Ivoclar Vivadent Inc, Patterson Companies, Inc., Mani, Inc., Coltene Holding AG, Micro Mega SA, and Danaher Corporation, among others.

Reduced Risk of Stroke and Atrial Fibrillation upon Use of Left Atrial Appendage Closure Device

The rising awareness regarding the side effects caused by anticoagulant drugs is expected to boost the demand for mechanical left atrial appendage closure devices in the appendage management market. According to the latest research by the company, the global appendage management market is projected to account for over US$ 352.5 Mn, in terms of value, by 2028 end. The report on the appendage management market further projects significant growth potential with average year-on-year growth rate pegged at 6.7% through 2028.

About 33.5 million people suffer from atrial fibrillation and according to the Centers for Disease Control and Prevention, approximately 130,000 patients suffering from atrial fibrillation die each year in the U.S. Atrial fibrillation increases the risk of stroke by five-fold and majority of individuals suffering from atrial fibrillation are aged 65 years and above. The appendage management market is categorized into epicardial and endocardial LAA closure devices for appendage management. The appendage management market is dominated by endocardial LAA closure device as epicardial LAA closure device is an emerging and a relatively new approach. Endocardial LAA closure devices segment contributes two-third of the total appendage management market share and is expected to continue to do so over the forecast period. Epicardial LAA closure devices segment in the appendage management market is expected to grow by 7.2% CAGR during the forecast period owing to their growing adoption and less complications associated with implantation of epicardial LAA closure devices as compared to endocardial LAA closure devices.

Request Report Sample@ https://www.futuremarketinsights.com/reports/sample/rep-gb-7752

LAA closure devices in the appendage management market are highly adopted in catheterization laboratories owing to the specialized function performed by the device, which can be efficiently implanted in the catheterization laboratories. Catheterization laboratories are specialized in diagnosis and treatment of problems, abnormalities and complications related to arteries and the chambers of the heart and play a vital role in the growth of the appendage management market. Moreover, the stent procedure used in implantation of the LAA closure devices is efficiently performed in catheterization laboratories contributing to the growth of the appendage management market. However, the growing popularity of LAA closure devices and their crossover success in clinical studies for safe and efficient occlusion of the left atrial appendage have increased their implementation in hospitals. Easy implantation features, advancing navigation and visualization technology and availability of products assisting in the implantation of LAA closure devices are further expected to contribute to the growing adoption of LAA closure devices by hospitals.

Owing to the presence of key players and higher healthcare expenditure, North America is projected to be the dominant region in the global appendage management market. Furthermore, the growing awareness amongst general population about atrial fibrillation and treatment against it as a precaution for heart stroke adds to the supremacy of the North America appendage management market. Europe is projected to be the prominent region in the global appendage management due to similar reasons. The Europe appendage management market is estimated to create incremental opportunity worth approximately US$ 49.0 Mn between 2018 and 2028. MEA is forecasted to behold high CAGR and potential to create a considerable revenue share in the global appendage management market. Regional penetration of manufactures and increased availability of LAA closure devices are likely to boost the growth of the appendage managements market in the MEA.

The company has segmented the global appendage management market based on product type, end user and region. In terms of revenue, the endocardial LAA closure device product type segment is expected to hold significant share over the forecast period. Additionally, the hospital end-use segment in the appendage management market is predicted to exhibit growth by 8.0% CAGR during the forecast period.

Methodology With Latest Advancements and Application @ https://www.futuremarketinsights.com/askus/rep-gb-7752

The report tracks some of the key companies operating in the appendage managements market, including Johnson & Johnson Services, Inc., Cardia, Inc., Abbott Laboratories, LifeTech Scientific Co., Ltd, Medtronic plc., SentreHEART, Inc., Boston Scientific Corporation, Occlutech International AB, AtriCure, Inc., etc.

Homecare Dermatology Energy-based Devices Market: Rising prevalence of skin problems has been leading to scarring

Fast-track FDA approvals play a vital role in new product launches, especially in the LED and lasers categories, according to a new FMI study.

Growing commercialization of advanced technology in homecare dermatology and frequent introduction of user-friendly dermatology services are collectively boosting the growth prospects for homecare dermatology energy-based devices landscape at a global level.

According to a newly released intelligence report by Future Market Insights, exhibiting nearly 5% year over year growth in revenue, the global homecare dermatology energy-based devices landscape is likely to be worth over US$ 550 Mn in 2020. While maximum incremental opportunity is projected for China and APEC, North America – despite being the global leader – is likely to witness moderate growth in coming years.

Rapidly growing demand for homecare devices as a result of a paradigm shift from conventional clinics to in-house, non-invasive energy treatments is prominently responsible for healthy revenue growth projections for homecare dermatology energy-based devices.

Technological advancements in these devices are widening their application base, thereby pushing the rate of adoption further at a global level. Another strong push factor associated with homecare dermatology energy-based devices includes their availability as the OTC products.

• Product type analysis of market landscape reveals that laser and IPL (intense pulsed light) equipment are enjoying the highest sales, whereas LED equipment is projected to emerge as the most attractive segment in homecare dermatology energy based devices space in the near future.
• Hair removal and acne, followed by wrinkles treatment, are reportedly the most extensively sought after applications of homecare dermatology energy based devices.
• E-commerce dominates all other distribution channels, according to the report. Hyper markets and super markets also remain among the preferred channels for product distribution.

Do Inquiry to Get the Sample of Report Here @ https://www.futuremarketinsights.com/reports/sample/rep-gb-7699 

A Bird’s Eye View of the Global Landscape

“The global market for homecare dermatology energy based devices is a highly consolidated landscape, wherein the top two players collectively account for around 60% share of the market revenue. Koninklijke Philips, with more than a third of the market value share, secures the top position with its extensive portfolio of intense pulsed light devices used for hair removal,” explains a senior research analyst while offering the inclusions of the company’s recent report on the global homecare dermatology energy based devices market.

Adding further to the information about the market competition, the analyst says, “A majority of companies are prioritizing product innovations in LED, IR, and lasers segments. Moreover, a large number of market players are taking efforts for extended product reach through retail partnerships, in addition to NPD for a wider application base. Companies are also observed to be focusing on collaborations and acquisitions to reshape their product distribution strategy for better profitability”.

FDA Approvals Are Relatively Easy

Relatively easy and faster FDA approvals for homecare dermatology energy based devices are driving improved appearance of these devices in tandem with the latest handheld gadgets, which prominently curtail the need for frequent visits to professional cosmetic treatment centers.

A recent example includes FDA clearance for Titan – the anti-aging device launched by Skinovations Inc. later in 2017.

On a similar line, North American and European markets for homecare dermatology energy based devices are witnessing remarkable adoption in recent years. FMI identifies a slew of business expansion opportunities in the aforementioned regions for manufacturers of homecare dermatology energy based devices.

Moreover, growing R&D efforts as manufacturers in the US zoom in on the production quality, is likely to shape the performance of North America’s market for homecare dermatology energy based devices.

Methodology With Latest Advancements and Application @ https://www.futuremarketinsights.com/askus/rep-gb-7699 

Combination of Technologies for Better Treatment Output

Making the most of the best attributes of LED and lasers technologies, a new trend among manufacturers now involves the combination of both the technologies for manufacturing homecare dermatology energy based devices. While these devices are claimed to be effectively reducing fine lines and improving skin tone with LED, lasers enable them to be highly target specific. A recent example is of YA-MAN’s RF Beaute Photo PLUS.

Trend Analysis of Endoscopy Fluid Management Systems 2019

Laparoscopy Suction Irrigation Pumps are likely to remain the top selling product type, whereas developing economies are projected to demonstrate impressive revenue growth in coming years.

Providing a brief overview of the FDA regulations for Class II medical devices such as endoscopes, a new study presented by Future Market Insights offers an exhaustive assessment of the global endoscopy fluid management systems landscape for a 10-year projection period, 2018-2028.

According to the FMI study, as the Tier 1 players continue to contribute over 70% share of the market revenue, the global endoscopy fluid management systems landscape remains a highly consolidated space.

The report covers extensive profiling of the top four performers including a few of the biggest industry names such as Stryker Corporation and Olympus Corporation. However, research indicates that even local players have strong penetration in regional markets.

To know key findings Request Sample Report @: https://www.futuremarketinsights.com/reports/sample/rep-gb-4358

Top 3 Insights from Key Players Analysis

• While a majority of companies are focusing on new product launches, strategic mergers and acquisitions are likely to emerge the most profitable developmental decisions in the near future.
• Most of these strategic moves will be primarily directed to address the high price point pressure associated with endoscopy fluid management systems that often affects revenue growth in developing economies.
• Major hospital networks in developed regional markets are witnessing M&A between hospitals, which is likely to shape costing of medical devices such as endoscopy fluid management systems – eventually slashing down the profitability margins of manufacturers.

“Constantly increasing chronic disease instances, coupled with immense technological advances in the field of endoscopy, is prominently driving the US$ 342 Million market for endoscopy fluid management systems (or irrigation pumps) in recent years,” says a senior research analyst at the company.

Top 5 Insights from Segmental Analysis

• With maximum use in laparoscopic procedures, endoscopy fluid management systems continue to register maximum revenue generation through sales of laparoscopy suction irrigation pumps, followed by laparoscopy fluid management systems.
• Based on the modality of endoscopy fluid management systems, the Benchtop holds a substantial market value share.
• Hospitals register the highest consumption of endoscopy fluid management systems.
• Owing to a massive number of cancer survivors in the US, North America’s market for endoscopy fluid management systems is currently accounting for the largest revenue share in the global landscape, followed by Asia Pacific and Europe.
• MEA and Latin America are likely to represent a significant incremental opportunity, according to FMI study.

Healthy Year over Year Revenue Growth Projected for Asia Pacific

APAC has become the hotspot for leading medical device companies, which is further intensified by dramatically growing medical tourism sector. Across APAC, Japan is likely to account for substantial revenue generation, enabling the regional market secure second spot in the global endoscopy fluid management systems landscape. FMI projects over 7% year on year revenue growth in 2020 and beyond, for this regional market.

Government Regulations Favor Market Growth in Latin America

Latin American market for endoscopy fluid management systems is thriving at a promising pace owing to favorable government initiatives regarding endoscopic procedures and medical device marketing. Noteworthy demand for laparoscopy suction irrigation pumps within the region is identified to be responsible for the rapid revenue growth of endoscopy fluid management systems marketplace across Latin America.

Request for Report customization @: https://www.futuremarketinsights.com/customization-available/rep-gb-4358

Egypt’s End Users Drive Market Growth in MEA

The market for endoscopy fluid management systems in MEA is prominently driven by the improving regulatory landscape related to the marketing of medical devices, pushed further by impressive sales of laparoscopy suction irrigation pump based endoscopy fluid management systems. FMI spots higher market attractiveness in Egypt owing to the presence of a large number of end users. However, poor operational environment still remains a major growth barrier for the region.

Increase in the prescription of sleep aids is expected to boost the market of narcolepsy treatment globally

Revenue from narcolepsy treatment, globally is projected to stand at a valuation of US$ 3,818 Mn, registering an annual growth rate of 5.7 percent, from 2018-2028. Future Market Insights (FMI), in its newly published market intelligence outlook, highlights substantial demand for narcolepsy treatment in North America. Narcolepsy treatment landscape in Europe, will witness significant revenue growth given the rising affinity toward adoption of prescription treatments and adherence to the same on a long term basis.

Asia Pacific among other emerging economies including MEA and Latin America, on the other hand, are expected to showcase positive trends towards the adoption of narcolepsy treatment, due to:

• Strong distribution pipeline of the narcolepsy drugs.
• Emerging global and local biopharmaceutical companies.
• Increasing incidences of Obstructive Sleep Apnea (OSA) in Latin America. Obesity is reported to be the most common risk factor.
• Prevalence of moderately severe sleep apnea is estimated to be around 5% in women and 10% in men in South Africa. It is estimated that up to 90% of patients are undiagnosed.
• Prevalence of sleep apnea is more severe in the developing countries due to the lack of skilled physicians

In term of key forward market strategies, the primary objective manufacturers in the narcolepsy treatment market is to expand their footprint in the various regional markets, in order to solidify their market position.

Request to View Sample of Research Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-7641 

Key Findings from the Regional and Competitive Landscape Analysis of Narcolepsy Treatment Market

• Leading narcolepsy treatment manufacturers are prioritizing regional-specific product development. The product portfolio expansion is mostly targeted in Asia Pacific.
• Apart from new product development—mostly arising from the presence of low cost generic versions of patented drugs, strategic partnerships and acquisitions with pave way for further business expansions.
• Manufacturers in the global narcolepsy treatment are also focused towards introducing new research and development units in different geographic regions.
• Industry leaders are focusing on maintaining long-term partnerships with pharmacies- in hospital and retail, drug stores, and e-commerce. Sales through e-commerce distribution channel is expected to contribute a significant revenue share in the global narcolepsy treatment market.
• FMI, has also noted an increasing focus on reformulation of well-known products and combinations, by manufacturers in North America in order to achieve higher sales and wide penetration.

There is a conscious shift from OTC medication to devices treating narcolepsy, driving significant revenue growth for the devices segment compared to drugs.  Growing incidences of inappropriate medication and addiction, translating into severe side effects including headache, prolonged drowsiness, daytime memory and performance problems, allergic reactions, and death in some cases, is the key driving factor. These side effects are associated with OTC as well as prescription-based sleep aids. Growing demand to treat narcolepsy with BiPAP is expected to push this segment of devices—predicted to expand at the highest CAGR. Moreover, devices in portable and available-for-rent formats, will translate into higher adoption rates, throughout the forecast period. Portable Continuous positive airway pressure (CPAP) devices are lighter and smaller and can also be used as a home based unit, further reducing the dependency on OTC pills and prescription drugs.

While explaining the growth trajectory of narcolepsy treatment market, a senior analyst from the healthcare domain underscores growing healthcare expenditure and rising incidence cases of fracture fixation and orthopedic disorders as key factors contributing to the demand of narcolepsy treatment though 2028. “Regulatory impositions by various global authorities including the FDA and European Commission along with currency fluctuations, regulations and changing taxation policies are some high-impact factors pushing the global demand for narcolepsy treatment”, the analyst further explains.

Need more information about Report methodology ? @ https://www.futuremarketinsights.com/askus/rep-gb-7641 

Critical Market Restrainers

Although the narcolepsy market is expanding at a robust CAGR, long waiting time for sleep services, lack of awareness and delayed diagnosis, severe side effects of sleep aids medication, lack of proper documentation for the usage and licensing of sleeping pills, and improper equipment regulations are some critical factors projected to restrain the growth of narcolepsy treatment market.

New Product Formulations Hold the Key to Undeterred Sales of Oxycodone

Growing cases and demand for pain management is increasing the number of referrals to pain management clinics, which is resulting in the growth of the oxycodone market. According to the latest research conducted by the Future Market Insights (FMI), the global oxycodone market is anticipated to account for over US$ 4,016.1 Mn, in terms of value, by 2028 end. The report further projects significant growth potential for the market, which is expected to expand at a CAGR of 4.6 % through 2028.

The market has been segmented by product type, applications, distribution channels and regions. The product type segment of the market includes long acting oxycodone and short acting oxycodone. The application segment of the market includes pain management and de-addiction. On the basis of distribution channel, the market has been segmented into retail pharmacies and hospital pharmacies. Based on product type, the long acting segment is expected to account for the largest share of 69.5 % in 2018 and is expected to grow at the highest CAGR of 4.9% during the forecast period.

The growth of the global oxycodone market is being primarily driven by the rise in the number of patients suffering from terminally ill diseases, severe cough resulting from lung infection, cancer and high surge in prescription for post-operative pain medication. These are some of the important factors expected to boost the consumption of opioids as a pain medicine.

Do Inquiry to Get the Sample of Report Here @ https://www.futuremarketinsights.com/reports/sample/rep-gb-7638

According to the Center for Disease Control and Prevention, in 2013, 239 million surgeries were conducted across the globe, of which 69 million were conducted in the U.S. Of all these 239 million surgeries, around 65% of the patients experienced moderate to severe post-operative pain. Opioid pain management drugs adoption is indirectly expanding the growth of the oxycodone market. However, poor efficiency and efficacy of oxycodone might hamper the growth of the oxycodone market during the forecast period. The companies operating in the market are involved in developing advanced formulations and new experimental drugs.

Concerns over opioid abuse and associated mortality due to opioid abuse are the primary restraints negatively impacting the concerned market. Opioid abuse deaths accounted for 49,000 of the 72,000 drug overdose deaths in the U.S. in 2017. According to the estimates presented by the center of disease control, about 66% of the 63,600 drug overdose deaths in 2016 involved the use of an opioid. On an average, 115 U.S. citizens die every day due to opioid overdose.

This oxycodone report assesses the trends that are driving the growth of each segment of the market at the global as well as regional level and offers potential takeaways that could prove substantially useful for manufacturers planning to enter the market.

View Full Report: https://www.futuremarketinsights.com/reports/oxycodone-market

North America is expected to be the dominant regional market for oxycodone and accounted for a high revenue share in 2017. The U.S. market is expected to account for a large share and is expected to grow at a CAGR of 5.9% over the forecast period. Europe and Asia Pacific are expected to grow at CAGRs of 4.8% and 4.2%, respectively. The developing regions, led by India and China, are expected to drive the future oxycodone market owing to their developing economies and expanding healthcare infrastructure.

The Middle East and Africa market is dominated by the gulf economies owing to their high per capita income and high public healthcare expenditure. The development of large hospital complexes in the Gulf nations will drive market adoption of oxycodone products.

FMI’s report tracks some of the key companies operating in the market, such as Purdue Pharma, Pfizer Inc., Janssen Pharmaceuticals Inc., Teva Pharmaceuticals, Endo Pharmaceuticals plc., Westward Pharmaceuticals, Mallinckrodt Pharmaceuticals, Mylan N.V., Impax Laboratories Inc. and Indivior plc., among others.

Methodology With Latest Advancements and Application @ https://www.futuremarketinsights.com/askus/rep-gb-7638

The companies operating in the oxycodone market are focusing on developing new drugs. Concerns over oxycodone use and the growing mortality from overdose are the primary constraints in the oxycodone market.

Government initiatives in cancer treatment to fuel growth of the global biopsy device market during the projected period

Key players focussing on strategic M&A for amplified market shares

Patients are increasingly preferring minimally invasive surgical procedures in order to avoid conventional surgical complications and side-effects, promoting sales of biopsy devices, leading to the growth of the biopsy devices globally. In addition to enabling the accurate diagnosis, a biopsy device assures minimal patient discomfort and trauma. This is identified to be a major factor impacting the popularity of biopsy, and biopsy device thereby.

Over the 10-year forecast period 2016-2026, the global biopsy device market is estimated to witness a moderate yet promising CAGR of 6.5%, according to Future Market Insights. In a recently published report titled “Global Biopsy Device Market: Global Industry Analysis and Opportunity Assessment, 2016–2026”, Future Market Insights analyses the market for biopsy device and offers key insights into the market condition for the aforementioned period. Valued at around US$ 1,397 Mn in 2016, the market will possibly attain the revenues beyond US$ 2,621 Mn by 2026-end.

To know key findings Request Sample Report @: https://www.futuremarketinsights.com/reports/sample/rep-gb-1192

Key Opportunities for Manufacturers and Suppliers, Grasped by Future Market Insights Research:

• Developing economies present lucrative, untapped markets for biopsy device.
• Growing adoption of hybrid imaging technology will underpin new growth opportunities.
• Following massive consumption by hospitals, demand for biopsy device from specific oncology centres and research institutes will prompt at multiple opportunities in near future.
• Surging demand for minimal invasive breast biopsy highlight lucrative opportunities that lie in the breast cancer sector.
• Increasing adoption of biopsy device by oncologists will generate several revenue generation opportunities in the disease monitoring sector.

Supported by increasing discretionary funding for cancer research, growing government expenditure for healthcare and favourable reimbursement scenario (especially in the U.S.) will collectively elevate the revenue sales of the global biopsy device market. Collaborations between various government and private companies, fuelled by increasing awareness about disease diagnosis and monitoring, will further elevate the market growth in near future.

M&A and Technological Upgrades Remain at the Forefront

A majority of key players in the global biopsy device market are currently focusing on providing innovative biopsy tests and technological upgrades. Mergers, acquisitions, and partnerships with diagnostic laboratories will help to strengthen their presence in the global market.  

Among the top companies, Becton, Dickinson and Company is concentrating on innovative, cost-effective product development, whereas Hologic, Inc. is targeting manufacture and sales of biopsy devices, especially for breast cancer surgeries. Other notable players include Boston Scientific Inc., C. R. Bard, Inc., B. Braun Melsungen AG, Cook Medical, INRAD Inc., and PLANMED OY.

Argon Medical, one of the promising new entrants, is expanding its product portfolio and collaborating with established players, whereas for Devicor Medical Products Inc., M&A remains the key strategy.

North America Retains the Most Lucrative Market, Developing Countries to Witness Impressive Growth over 2016-2026

North America will remain the dominant market, reaching nearly US$ 882 Mn by 2026 end, accounting for over 33% share of the market. Western Europe is expected to remain the second largest market for biopsy device, crossing a value of US$ 683 Mn by the end of 2026, capturing over 26% share of the market.

APEJ, with around 14% market value share in 2026, is likely to reach US$ 370.0 Mn by the end of forecast period. MEA will register the fastest CAGR of 7.3%, followed by APEJ and Latin America with the respective CAGRs of 7.1% and 6.5% over 2016-2026. North America, Europe, and Japan will see moderate growth over the forecast period.

Needles Continue to Drive Product Type Segment

By product type, needles will remain dominant with over 36% share of the market value in 2026, whereas guns will represent the second largest sub-segment with over 26% market value share in 2026. With growing significance of early diagnosis of breast biopsy, guidance system segment is estimated to gain around 222 BPS in its market share by 2026 over 2016. Stereostatic X-ray guided biopsy will drive the guidance system segment through to 2026. Reagents and kits will witness moderate consumption.

Medical Diagnostics Monopolise Application Segment

Based on application type, medical diagnostics will continue to hold a dominant share of over 61% by 2026 end, in terms of revenues. Scientific research, accounting for the rest, will witness an impressively growing CAGR of 6.9% over 2016-2026. This segment is expected to reach beyond US$ 1,008.0 Mn in 2026.

Request for Report customization @: https://www.futuremarketinsights.com/customization-available/rep-gb-1192

Hospitals Remain Largest End-use Consumer

By end-user, hospitals will continue to contribute nearly 50% share to the market value by 2026 end. This end-use segment will witness a robust CAGR of 8.2%. Diagnostic centres will account for over 23% in 2026 with a slight decline over 2016-2026, whereas specialised oncology centres are anticipated to expand at a CAGR of 6.1% during 2016-2026.

Global Microfluidics Market Poised for Robust CAGR of over 14% through 2026

Applications of microfluidics in drug delivery and diagnostics will continue to fuel the market for microfluidics over the next few years. “The US$ 2.9 Bn microfluidics market will possibly cross US$ 11 Bn by the end of 2026. North America is expected to contribute over US$ 3 Bn to the total revenues in 2026. The collective share of North America and Asia Pacific will be over 40%,” states Future Market Insights in a recently published market report outlook, titled “Microfluidics Market: Global Industry Analysis and Opportunity Assessment, 2016-2026.”

The report by Future Market Insights analyses the global market for microfluidics over a 10-year forecast period, 2016-2026. The market is likely to witness a robust CAGR of 14.4% over the assessed period.

To know key findings Request Sample Report @: https://www.futuremarketinsights.com/reports/sample/rep-gb-398

Key Insights: Market Dynamics

• Increasing discretionary funding from national labs for R&D in the developed regions will remain a primary factor driving the growth of market through 2026.
• Improving healthcare infrastructure and wide availability of affordable microfluidic devices or kits are also foreseen to boost the market growth in near future, especially in developing countries.
• Expansion of drug delivery sector will favour the market growth in near future.
• Consistent advancements in the fields of genomics and proteomics are also expected to benefit the sales of microfluidics-based devices and kits.
• Dynamic collaborations between key market players and active involvement of government entities will collectively foster the market through 2026.

Key Insights: Segments

Ceramics will remain dominant material type

Based on material, ceramics will continue to be the most sought after material for microfluidic device or kit manufacturing. Ceramics segment is expected to remain dominance, accounting for over 42% market value share in 2026, followed by glass, polymer, and silicon. While ceramics is likely to witness the fastest growth, polymer segment is anticipated to exhibit a significant CAGR of over 15% over 2016-2026, driven by PVC.

POCT will be dominant application segment

By application, POCT (point of care testing) segment is projected to retain dominance through 2026, accounting for over 33% share in terms of revenues. Clinical diagnostics and analytical testing will remain the next major segments in the global microfluidics market.

In-vitro diagnostics industry will hold maximum revenue share

On the basis of industry, in-vitro diagnostics, life science research, and pharmaceuticals are likely to be the key segments. In-vitro diagnostics segment is estimated to hold a share of over 35% in the total market revenues. The fastest growing segment will be in-vitro diagnosis.

APEJ will be the most lucrative regional market

Geographically, North America, followed by Western Europe are expected to remain the dominant regions for microfluidics, capturing respective market value share of over 26% and over 21% share by 2026 end. Asia Pacific (excluding Japan) will possibly represent the most lucrative market, expanding at a significant CAGR of over 14% throughout the forecast period. This growth is attributed to growing use of microfluidics devices and kits for in-vitro diagnostics. North America and Western Europe will also exhibit significant growth rates over 2016-2026. 

Key Insights: Leading Market Players

Some of the most prominent players in the global microfluidics market, include Agilent Technologies, PerkinElmer Inc., Thermo Fisher Scientific Inc., Qiagen NV, Bio-Rad Laboratories, Inc., Fluidigm Corporation, Abbott Laboratories, and F. Hoffmann-La Roche Ltd.

Request for Report customization @: https://www.futuremarketinsights.com/customization-available/rep-gb-398

Almost all the leading companies serve point of care testing application and survive the competition with an individual differentiating strategy. Thermo Fisher Scientific Inc. and Abbott Laboratories, through active engagement in agreements and collaborations with leading regional companies, highlight a growing trend of strategic mergers and acquisitions among the top companies.

Aromatherapy Market: Essential Oils Will Continue to Rule Consumer Preferences Owing to Their Therapeutic Benefits

A recent study of Future Market Insights (FMI) envisages the aromatherapy market to record a healthy 7.7% value CAGR and reach US$ 8,058.5 million valuation between the period of forecast 2016 and 2026. The market is expected to experience promising growth in the near future, mainly due to the increasing health and wellness trend, and popularity of the direct sales channel. Medical centers offering therapeutic treatments have initiated promotions for the use of aromatherapy in the treatment of generic ailments such as headaches, anxiety and depression. Increasing preference for aromatherapy will also be instrumented by its efficiency in boosting cognitive performance, increasing blood circulation, strengthening immunity, improving digestion and reducing pain.

To know key findings Request Sample Report @: https://www.futuremarketinsights.com/reports/sample/rep-gb-1080

The regions of North America and Western Europe are projected to continue their dominance in the aromatherapy market. Collective revenues from aromatherapy product sales in these two regions will surpass US$ 4 billion, according to the study. However, Asia Pacific excluding Japan (APEJ) will record fastest growth in the aromatherapy market, as spa tourism is on the go in ASEAN markets, and an increasing number of women in this region are inclined to buy essential oils for home usage.

Diffusers and other equipment used for extracting the aroma of plant extracts will continue to witness a slower sales growth rate as compared to consumables. Revenues from aromatherapy consumables, such as blended oils, carrier oils, will account for bulk shares of the market during the forecast period. There has been increasing usage of aromatherapy diffusers at home to ward off bad smells. The therapeutic properties of essential oils such as immune system, combating cold, allergies and breathing disorders are promoting sound sleep and relaxation at home. As a result, increasing number of people are opting to buy aromatherapy diffusers and essential oils for home usage.

Aromatherapy acts as a complementary treatment in many viral and bacterial diseases such as acute respiratory infections, viral infections, influenza, and bronchitis, and can be used during prophylactic and therapeutic treatment regime for many diseases. Owing to these added benefits and application of essential oils in many indications leads to increasing sales of essential oils for different condition which in turn drive the revenue growth of aromatherapy market.

Increasing consumer preference for aromatherapy can be attributed to its greater skin rejuvenation and hair fall control offered. This has further driven adoption of aromatherapy in skin care and hair care applications, with revenues projected to register an impressive growth through 2026. Demand for aromatherapy is also expected to rise in the treatment of insomnia, pain management, and scar management. Carrot seed, cedar wood, geranium, hyssop, juniper, rose and lavender essential oils are commonly used for scar management.

Aromatherapy market is fragmented with the presence of few established brands and many local players in the market, and the market is witnessing entry of many home-based and startup firms. The major share of market is captured by the brands such as Young Living Essential Oils, doTERRA, Now foods and Eden Garden.

Request for Report customization @: https://www.futuremarketinsights.com/customization-available/rep-gb-1080

Considering the growth prospects in emerging markets, various established companies and startup firms have entered aromatherapy market to capture maximum share in emerging markets, as the market is at its nascent stage where herbal products are in high demand. Companies such as Mountain Rose Herbs, Eden Garden, Frontier Natural Products Co-op (Aura Cacia) and Plant Therapy Essential Oils based in the U.S. are recognized all over the world for offering organic herbs, aromatherapy products, essential oils, and other natural health and body care products through online big retail chains and through their own website.

Two U.S. based companies are likely to dominate the global surgical stapling devices market in terms of market share

With deployment of advanced technologies, medical practitioners will keep adopting specialised devices that facilitate specific surgical operations in medical procedures. Rising number of invasive surgeries has necessitated the need for improved devices for wound management. And, surgical staples have effectively replaced sutures for closing wounds during such procedures. Future Market Insights recently published its report on the global market for surgical stapling devices, the highlights from which indicate that rising number of laparoscopic surgeries performed across the globe have triggered the use of surgical stapling devices. 

To know key findings Request Sample Report @: https://www.futuremarketinsights.com/reports/sample/rep-gb-867

According to Future Market Insights, the global demand for surgical stapling devices is propelling along with the world’s rising geriatric population. Lesser time consumed by surgical stapling devices for closing wounds, and the accuracy & precision of these devices is favouring their adoption for treating wounds of aged patients. In 2016, close to US$ 2,000 Mn worth of surgical stapling devices were sold in the world. The report projects that these revenues will be doubled by the end of 2026, projecting that the global surgical stapling devices market will soar steadily at 7.6% CAGR. 

In the report, titled “Surgical Stapling Devices Market: Global Industry Analysis and Opportunity Assessment, 2016-2026,” North America has been identified as the largest market for surgical stapling devices. By the end of forecast period, more than US$ 1,000 Mn revenues will be solely attributed by North America’s surgical stapling devices market. Advanced healthcare infrastructure in Western Europe has facilitated the region’s surgical stapling devices market, which will register a value CAGR of 7.9% through 2026. Although, fastest consumption of surgical stapling devices will be witnessed in the Asia-Pacific excluding Japan (APEJ) region. The APEJ surgical stapling devices market is expected to soar at the highest CAGR of 8.6%. 

Leading Manufacturers of Surgical Stapling Devices: Medtronic plc, Grena Ltd., Purple Surgical Holdings Limited, Dextera Surgical Inc., Johnson & Johnson Services, Inc., 3M Company, and Meril Life Sciences Pvt. Ltd. 

The report reveals that hospitals will remain the largest end-users of surgical stapling devices in the world – accounting for more than 60% of global revenues. Meanwhile, the demand for surgical stapling devices will also gain traction in ambulatory surgical centres. Key findings in the report indicate that powered surgical stapling devices worth US$ 1,182 Mn were sold globally in 2016, while the demand for manual surgical stapling products is anticipated to incur a downtrend in the years to come. 

Throughout the forecast period, six out of ten surgical stapling devices sold in the world are likely to be disposable, while revenues from reusable surgical stapling products will be growing at a sluggish rate. Preference to curved surgical stapling is also on a rise, revenues from which are expected to soar impressively at 9% CAGR. 

Request for Report customization @: https://www.futuremarketinsights.com/customization-available/rep-gb-867

Dermatological surgeries will undoubtedly require greater number of surgical stapling devices. The report estimates that in 2016, nearly US$ 600 million revenues were amassed from the sales of surgical stapling devices in treatment of skin-related surgical wounds. The use of advanced surgical stapling devices is also expected to gain momentum for closing dissected or ruptured blood vessels during surgeries. Wounds situated in the patient’s digestive tract are also being treated by surgical stapling, and by the end of 2026, around US$ 665 million worth of devices will be consumed for such treatments.